Heavyweight opposition could seal fate of $4bn medtech tax
This article was originally published in Clinica
Executive Summary
US industry association lobbyists have helped mobilise an impressive defensive against the proposed $4bn medtech tax currently casting a dark cloud over US manufacturers.